Novel thyroid receptor ligands are provided which have the general formula (I)where R1 is alkyl of 1 to 4 carbons or cycloalkyl of 3 to 7 carbons; R2 and R3 are the same or different and are hydrogen, halogen, alkyl of 1 to 3 carbons or cycloalkyl of 3 to 5 carbons, at least ...
TUESDAY, March 23, 2021 (HealthDay News) -- The first drug approved in the United States to treat thyroid eye disease may come with an unwelcome side effect for many: A small, new study finds that up to two-thirds of patients who take the medication experience hearing problems. Teprotum...
main Data cleveland-0_vs_4.csv dermatology-6.csv ecoli-0-4-6_vs_5.csv ecoli-0-6-7_vs_5.csv glass-0-1-4-6_vs_2.csv glass0.csv glass5.csv led7digit-0-2-4-5-6-7-8-9_vs_1.csv new-thyroid1.csv page-blocks0.csv pima.csv poker-8-9_vs_5.csv poker-8-9_vs_6.csv...
Finding a new therapeutic target that can be used as an alternative after the failure of or in association with chemotherapy to improve the tumor response and prognosis is currently an urgent demand and consequently a very interesting area of research. It is already known that the thyroid hormone...
p68 甲状腺如何管理新陈代谢 How does the thyroid manage your metabolism。听TED演讲,看国内、国际名校好课,就在网易公开课
"These results suggest that anlotinib neoadjuvant treatment represents a new option for locally advanced thyroid cancer," said Wang.■
A skin treatment composition for topical application comprises: at least one thyroid hormone compound or thyroid hormone-like compound, wherein said thyroid hormone compound or thyroid hormone-like compound is a chemical entity which binds to TR alpha or TR beta with a dissociation constant, Kd, ...
Thyroid fine-needle aspiration was traditionally practised freehand although in recent years the majority of thyroid fine-needle aspirations are now taken under ultrasound guidance. While thyroid fine-needle aspiration practice has changed relatively little, new molecular technologies have developed apace. ...
Thyroid cancer, the most common cancer of the endocrine glands, is the fastest rising cancer in women and second fastest rising in men in the U.S. The new gene, SEC23B, discovered by Charis Eng, MD, PhD, Founding Chair of the Genomic Medicine Institute within Cleveland Clinic's Lerner Re...
Aim:Employees of Sanofi-Aventis Deutschland GmbH underwent thyroid screening in 2006 to assess new data about the prevalence of irregular sonomorphological pattern, elevated thyroid peroxidase antibodies (TPO AB) and thyroid function in an unselected adult German population.Participants, methods:The examina...